Abstract

Purpose

SARS-CoV-2 causes a severe inflammatory syndrome (COVID-19) leading, in many cases, to bilateral pneumonia, severe dyspnea and in ~5% of these, death. DNA methylation is known to play an important role in the regulation of the immune processes behind COVID-19 progression, however it has not been studied in depth. In this study, we aim to evaluate the implication of DNA methylation in COVID-19 progression by means of a genome-wide DNA methylation analysis combined with DNA genotyping.

Methods

We integrated genetic and blood DNA methylation information, analysed them together with clinical information in a sample of ~100 healthy controls and ~470 SARS-CoV-2 PCR tested patients recruited from two different clinical centers and compared with seven different systemic autoimmune diseases (SADs) from the PRECISESADS cohort.

Results

The EWAS revealed widespread epigenetic variation associated with COVID-19 phenotypes, which were enriched in molecular pathways related with SADs and differed between mild and severe COVID19 cases. Among them, interferon, FCGR mediated phagocytosis and CD209 signatures in severe and mild COVID-19 were shared with seven different SADs (including systemic lupus erythematosus). Environmental trait-related CpG sites were found to be specifically hypermethylated in mild SARS-CoV-2 positive cases. These sites were enriched in key regulators of inflammatory cytokine gene expression known to be part of the cytokine storm described in the most severe outcomes of the disease. Additionally, these DNA methylation changes were found to be differentially regulated by genetic variants and associated with different regulatory mechanisms.

Conclusions

The results reveal the existence of epigenomic regulation of functional pathways associated with COVID-19 progression and mediated by genetic loci. Our work reveals pathways involved in COVID19 pathogenesis both shared and not shared with SADs, novel risk variants with epigenetic downstream effects, and illustrate how the genetic architecture of DNA methylation depends on the infection status and severity of COVID19. In addition, the analyses suggest that an interaction between environment, genetics and epigenetics might be playing a role in triggering the cytokine storm described in the most severe cases.

Details

Title
PO.8.165 Whole-blood dna methylation analysis reveals respiratory environmental traits involved in COVID-19 severity following SARS-CoV-2 infection
Author
Barturen, G; Carnero-Montoro, E; Martínez-Bueno, M; Rojo-Rello, S; Sobrino, B; Alcántara-Domínguez, C; Bernardo, D; Alarcón-Riquelme, ME
Pages
A119-A120
Section
Friday 07 October 2022 from 13:00 to 14:10
Publication year
2022
Publication date
2022
Publisher
BMJ Publishing Group LTD
e-ISSN
20538790
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2724395249
Copyright
© 2022 Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/ This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ . Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.